{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:45:55Z","timestamp":1787507155628,"version":"build-2736575974"},"reference-count":43,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100009750","name":"Medical Center, University of Rochester","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009750","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018645","name":"Musculoskeletal Research Center, Washington University in St. Louis","doi-asserted-by":"publisher","award":["5P30AR069655"],"award-info":[{"award-number":["5P30AR069655"]}],"id":[{"id":"10.13039\/100018645","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.jid.2022.03.033","type":"journal-article","created":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T02:11:54Z","timestamp":1652839914000},"page":"2885-2895.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Prominent B-Cell Signature Differentiates Discoid from Subacute Cutaneous Lupus Erythematosus"],"prefix":"10.1016","volume":"142","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1410-7856","authenticated-orcid":false,"given":"Irina","family":"Lerman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5589-5361","authenticated-orcid":false,"given":"Fatima","family":"Bawany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3910-1656","authenticated-orcid":false,"given":"Wade","family":"Whitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2801-0310","authenticated-orcid":false,"given":"Fatema","family":"Esaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0463-1470","authenticated-orcid":false,"given":"Joshuah","family":"Yon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9282-459X","authenticated-orcid":false,"given":"Nicole","family":"Babkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6168-208X","authenticated-orcid":false,"given":"Maxwell B.","family":"Rapp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5820-604X","authenticated-orcid":false,"given":"Glynis A.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1450-1549","authenticated-orcid":false,"given":"Jennifer H.","family":"Anolik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7692-1768","authenticated-orcid":false,"given":"Christopher T.","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2022.03.033_bib2","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.coi.2019.09.004","article-title":"B\u00a0cell targeted therapies in autoimmune disease","volume":"61","author":"Barnas","year":"2019","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.jid.2022.03.033_bib3","first-page":"1244","article-title":"Molecular profiling of cutaneous lupus lesions identifies subgroups distinct from clinical phenotypes","volume":"8","author":"Berthier","year":"2019","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.jid.2022.03.033_bib4","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/BOR.0000000000000201","article-title":"New insights into B cell biology in systemic lupus erythematosus and Sjogren's syndrome","volume":"27","author":"Bird","year":"2015","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.jid.2022.03.033_bib5","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.ijwd.2019.07.004","article-title":"Cutaneous lupus erythematosus: a review of the literature","volume":"5","author":"Blake","year":"2019","journal-title":"Int J Womens Dermatol"},{"key":"10.1016\/j.jid.2022.03.033_bib6","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jdermsci.2013.11.007","article-title":"Differential expression of BAFF and its receptors in discoid lupus erythematosus patients","volume":"73","author":"Chong","year":"2014","journal-title":"J\u00a0Dermatol Sci"},{"key":"10.1016\/j.jid.2022.03.033_bib7","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.revmed.2019.12.004","article-title":"[Resistant and progressive cutaneous lupus erythematosus treated with Belimumab: A retrospective monocentric study]","volume":"41","author":"Dresco","year":"2020","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.jid.2022.03.033_bib8","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1084\/jem.20050879","article-title":"Expression\u00a0of the immunoregulatory molecule FcRH4 defines a distinctive tissue-based population of memory B cells","volume":"202","author":"Ehrhardt","year":"2005","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jid.2022.03.033_bib9","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jaut.2017.03.012","article-title":"FcRL4+ B-cells in salivary glands of primary Sjogren's syndrome patients","volume":"81","author":"Haacke","year":"2017","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jid.2022.03.033_bib10","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1177\/0961203313497115","article-title":"Effects of rituximab-based B-cell depletion therapy on skin manifestations of lupus erythematosus--report of 17 cases and review of the literature","volume":"22","author":"Hofmann","year":"2013","journal-title":"Lupus"},{"key":"10.1016\/j.jid.2022.03.033_bib11","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1080\/00313020802320739","article-title":"Evaluation of the profile of the immune cell infiltrate in lichen planus, discoid lupus erythematosus, and chronic dermatitis","volume":"40","author":"Hussein","year":"2008","journal-title":"Pathology"},{"key":"10.1016\/j.jid.2022.03.033_bib12","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.immuni.2018.08.015","article-title":"Distinct effector B cells induced by unregulated toll-like receptor 7 contribute to pathogenic responses in systemic lupus erythematosus","volume":"49","author":"Jenks","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.jid.2022.03.033_bib13","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1136\/annrheumdis-2021-220349","article-title":"B\u00a0cell subset composition segments clinically and serologically distinct groups in chronic cutaneous lupus erythematosus","volume":"80","author":"Jenks","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jid.2022.03.033_bib14","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1016\/S0140-6736(17)30070-3","article-title":"First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial","volume":"389","author":"Joly","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jid.2022.03.033_bib15","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1136\/ard.2007.074229","article-title":"Assessment of rituximab's immunomodulatory synovial effects (ARISE trial). 1: clinical and synovial biomarker results","volume":"67","author":"Kavanaugh","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jid.2022.03.033_bib16","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.1016\/j.jid.2021.04.030","article-title":"Gene expression profiling in the skin reveals strong similarities between subacute and chronic cutaneous lupus that are distinct from lupus nephritis","volume":"141","author":"Ko","year":"2021","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2022.03.033_bib17","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1093\/ndt\/gfaa117","article-title":"Long-term effects of combined B-cell immunomodulation with rituximab and belimumab in severe, refractory systemic lupus erythematosus: 2-year results","volume":"36","author":"Kraaij","year":"2021","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jid.2022.03.033_bib18","doi-asserted-by":"crossref","first-page":"440","DOI":"10.21037\/atm-20-5185","article-title":"Human cutaneous B cells: what do we really know?","volume":"9","author":"Lerman","year":"2021","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.jid.2022.03.033_bib19","doi-asserted-by":"crossref","first-page":"4064","DOI":"10.4049\/jimmunol.1501027","article-title":"Fc receptor-like 5 expression distinguishes two distinct subsets of human circulating tissue-like memory B cells","volume":"196","author":"Li","year":"2016","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jid.2022.03.033_bib20","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/intimm\/dxaa053","article-title":"Fc receptor-like 4 and 5 define human atypical memory B cells","volume":"32","author":"Li","year":"2020","journal-title":"Int Immunol"},{"key":"10.1016\/j.jid.2022.03.033_bib21","first-page":"81","article-title":"Cutaneous lupus erythematosus: current and future pathogenesis-directed therapies","volume":"93","author":"Little","year":"2020","journal-title":"Yale J Biol Med"},{"key":"10.1016\/j.jid.2022.03.033_bib22","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1136\/annrheumdis-2011-200831","article-title":"Effects of belimumab, a B lymphocyte stimulator-specific inhibitor, on disease activity across multiple organ domains in patients with systemic lupus erythematosus: combined results from two phase III trials","volume":"71","author":"Manzi","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jid.2022.03.033_bib23","doi-asserted-by":"crossref","first-page":"e341","DOI":"10.1111\/ajd.13514","article-title":"Refractory discoid lupus erythematosus responds to rituximab","volume":"62","author":"Mumford","year":"2021","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.jid.2022.03.033_bib24","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jdermsci.2016.12.004","article-title":"Changes in T cell and B cell composition in discoid lupus erythematosus skin at different stages","volume":"85","author":"O'Brien","year":"2017","journal-title":"J\u00a0Dermatol Sci"},{"key":"10.1016\/j.jid.2022.03.033_bib25","doi-asserted-by":"crossref","first-page":"38","DOI":"10.2174\/1874312900802010038","article-title":"Resistance to rituximab therapy and local BAFF overexpression in Sjogren's syndrome-related myoepithelial sialadenitis and low-grade parotid B-cell lymphoma","volume":"2","author":"Quartuccio","year":"2008","journal-title":"Open Rheumatol J"},{"key":"10.1016\/j.jid.2022.03.033_bib26","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1001\/jamadermatol.2018.3793","article-title":"Assessment of response to B-cell depletion using rituximab in cutaneous lupus erythematosus","volume":"154","author":"Quelhas da Costa","year":"2018","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jid.2022.03.033_bib27","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1080\/14728222.2018.1472768","article-title":"Update on Fc receptor-like (FCRL) family: new immunoregulatory players in health and diseases","volume":"22","author":"Rostamzadeh","year":"2018","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.jid.2022.03.033_bib28","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1016\/j.jaad.2020.05.058","article-title":"Belimumab for refractory manifestations of cutaneous lupus: a multicenter, retrospective observational study of 16 patients","volume":"83","author":"Salle","year":"2020","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jid.2022.03.033_bib29","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.7326\/M21-2078","article-title":"Effectiveness of belimumab after rituximab in systemic lupus erythematosus : a randomized controlled trial","volume":"174","author":"Shipa","year":"2021","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jid.2022.03.033_bib30","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.3389\/fimmu.2018.02285","article-title":"BAFF and BAFF-receptor in B cell selection and survival","volume":"9","author":"Smulski","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jid.2022.03.033_bib31","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1097\/TP.0b013e3181735723","article-title":"B\u00a0cell survival in intragraft tertiary lymphoid organs after rituximab therapy","volume":"85","author":"Thaunat","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.jid.2022.03.033_bib32","doi-asserted-by":"crossref","first-page":"925805","DOI":"10.1155\/2014\/925805","article-title":"Site-specific analysis of inflammatory markers in discoid lupus erythematosus skin","volume":"2014","author":"Thorpe","year":"2014","journal-title":"ScientificWorldJournal"},{"key":"10.1016\/j.jid.2022.03.033_bib33","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/JLB.4RU0221-102RR","article-title":"Lymphocytes sense antibodies through human FCRL proteins: emerging roles in mucosal immunity","volume":"111","author":"Tolnay","year":"2022","journal-title":"J\u00a0Leukoc Biol"},{"key":"10.1016\/j.jid.2022.03.033_bib34","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1177\/0961203316682097","article-title":"Belimumab for the treatment of recalcitrant cutaneous lupus","volume":"26","author":"Vashisht","year":"2017","journal-title":"Lupus"},{"key":"10.1016\/j.jid.2022.03.033_bib35","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13000-020-00974-4","article-title":"Comparison of skin biopsy sample processing and storage methods on high dimensional immune gene expression using the Nanostring nCounter system","volume":"15","author":"Vider","year":"2020","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.jid.2022.03.033_bib36","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1002\/art.39085","article-title":"Brief report: responses to rituximab suggest B cell-independent inflammation in cutaneous systemic lupus erythematosus","volume":"67","author":"Vital","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jid.2022.03.033_bib37","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/exd.13419","article-title":"High expression of B lymphocyte stimulator in lesional keratinocytes of patients with cutaneous lupus erythematosus","volume":"27","author":"Wenzel","year":"2018","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jid.2022.03.033_bib38","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1111\/j.1365-2133.2007.08137.x","article-title":"The expression pattern of interferon-inducible proteins reflects the characteristic histological distribution of infiltrating immune cells in different cutaneous lupus erythematosus subsets","volume":"157","author":"Wenzel","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2022.03.033_bib39","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMoa2028564","article-title":"Rituximab versus mycophenolate mofetil in patients with pemphigus vulgaris","volume":"384","author":"Werth","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jid.2022.03.033_bib40","doi-asserted-by":"crossref","first-page":"83","DOI":"10.5582\/bst.2011.v5.2.83","article-title":"Immunohistochemical characterization of the cellular infiltrate in discoid lupus erythematosus","volume":"5","author":"Xie","year":"2011","journal-title":"Biosci Trends"},{"key":"10.1016\/j.jid.2022.03.033_bib41","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1136\/annrheumdis-2013-204116","article-title":"Expression of FcRL4 defines a pro-inflammatory, RANKL-producing B cell subset in rheumatoid arthritis","volume":"74","author":"Yeo","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jid.2022.03.033_bib42","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1016\/j.jid.2017.05.032","article-title":"Pivotal role of lesional and perilesional T\/B lymphocytes in pemphigus pathogenesis","volume":"137","author":"Yuan","year":"2017","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2022.03.033_bib43","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jid.2019.07.717","article-title":"Autoreactive B cell differentiation in diffuse ectopic lymphoid-like structures of inflamed pemphigus lesions","volume":"140","author":"Zhou","year":"2020","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2022.03.033_bib1","unstructured":"Aranow C, Allaart C, Amoura Z, Bruce I, Cagnoli P, Furie R, et al. Efficacy and safety of subcutaneous belimumab (BEL) and rituximab (RTX) sequential therapy in patients with systemic lupus erythematosus: the phase 3, randomized, placebo-controlled BLISS-BELIEVE study. Paper presented at: American College of Rheumatology Meeting 2021. 22 October, 2021; Virtual meeting."}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X22003694?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X22003694?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T21:49:39Z","timestamp":1762206579000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X22003694"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":43,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S0022202X22003694"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2022.03.033","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prominent B-Cell Signature Differentiates Discoid from Subacute Cutaneous Lupus Erythematosus","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2022.03.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}